First case of stenting of a vulnerable plaque in the SECRITT I trial—the dawn of a new era?

Steve Ramcharitar; Nieves Gonzalo; Robert‐Jan van Geuns; Héctor M. García‐García; Joanna J. Wykrzykowska; Jürgen Ligthart; Evelyn Regar; Patrick W. Serruys

doi:10.1038/nrcardio.2009.34

Related publications

Letter2020

Twilight, the Dawn of a New Era of Aspirin-Free PCI?

Patrick W. Serruys, Kuniaki Takahashi, Ply Chichareon, Yoshinobu Onuma

Journal of the American College of Cardiology

Article2003

Detection of a Vulnerable Coronary Plaque

Chourmouzios A. Arampatzis, Jürgen Ligthart, Johannes A. Schaar, Koen Nieman, Patrick W. Serruys, Pim J. de Feyter

Circulation

Article2010

INCOMPLETE THREE-VESSEL INTRAVASCULAR IMAGING IN THE PROSPECT TRIAL: IMPLICATIONS FOR PRE-EMPTIVE VULNERABLE PLAQUE DETECTION

Akiko Maehara, Gary S. Mintz, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, George Dangas, Barry Templin, John McPherson, Bernard De Bruyne, Naim Farhat, Bertil Wennerblom, Andrés Íñiguez, Steven P. Marso, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

Article2014

How can the vulnerable plaque be identified

Carlos M. Campos, Christos V. Bourantas, Héctor M. García‐García, Pedro A. Lemos, Patrick W. Serruys

Dialogues in Cardiovascular Medicine

Article2004

Detection and treatment of vulnerable plaque

Patrick W. Serruys, Marco Valgimigli